CRL · Earnings call · 2026Q2T · Full report
Liquidity and Debt Position
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · 2026-08-05 · Importance 19 · Surprise 6 · In source text
Net leverage improved slightly to 2.5x at the end of the second quarter, even after the company completed a $100 million share repurchase. Net interest expense was $28 million in the quarter, down $1.2 million year over year. Full-year non-GAAP net interest expense guidance remains $103 million to $108 million. Management said strong cash generation, ample revolver capacity, and attractive borrowing rates support the acquisition strategy.
Key facts
- Charles River repurchased $100 million in shares in Q2 at approximately $174 per share, and after that repurchase, leverage remained around 2.5x with strong cash flows and capacity under its revolver to support acquisitions.
- Net interest expense was $28 million in the second quarter, a decline of $1.2 million year-over-year; full-year net interest expense outlook remains $103 million to $108 million on a non-GAAP basis.
- At the end of the second quarter, Charles River's net leverage improved slightly to 2.5x from the first quarter.
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| net_income | positive | realized | +0.1% | Net interest expense was $28 million in the second quarter, a decline of $1.2 million year-over-year; full-year net interest expense… |
| net_income | negative | committed | — | Net interest expense was $28 million in the second quarter, a decline of $1.2 million year-over-year; full-year net interest expense… |